Breast Cancer Trial, Recruiting (NCT06759714)

Breast Cancer Trial, Recruiting NCT06759714 Sponsor: Ain Shams University Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06759714 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Female breast cancer patients who are Egyptian, aged 18 years or older, and have been newly diagnosed with breast cancer.

Who may not be able to join:

People who have a blood disease.
People who have any type of cancer other than breast cancer.
People who have liver cirrhosis (scarring of the liver).
People who have a uterine (womb) or urinary bladder disease.
Breast cancer patients whose cancer has already spread to distant parts of the body (known as distant metastases).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sherihan Galal, phD, Ain Shams University

Phone: 01022850699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06759714

Sponsor: Ain Shams University

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 01022850699

More information: https://clinicaltrials.gov/study/NCT06759714

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Female breast cancer patients who are Egyptian, aged 18 years or older, and have been newly diagnosed with breast cancer.

Who may not be able to join:

People who have a blood disease.
People who have any type of cancer other than breast cancer.
People who have liver cirrhosis (scarring of the liver).
People who have a uterine (womb) or urinary bladder disease.
Breast cancer patients whose cancer has already spread to distant parts of the body (known as distant metastases).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ain Shams University

Registry

ClinicalTrials.gov

Start date

23 November 2024

Est. completion

1 May 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Elucidate the role of our candidate lncRNAs and their downstream targets obtained from breast cancer patients' liquid biopsy and/or tissue samples.; Compare the expression level of lncRNA UPK1A- AS1 and/or UNC5B-AS1 and their target miRNAs in serum samples (liquid biopsy) and/or tissue samples from breast cancer patients, using (qRT-PCR) to their expression in healthy volunteers; Compare serum and/or tissue target proteins level, by ELISA to their levels in healthy volunteers.; Correlate these ncRNAs and target protein level axis, to the clinicopathological characteristics of breast cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov